{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:02Z","timestamp":1786120382863,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1097\/ccm.0000000000007169","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:00:38Z","timestamp":1785852038000},"page":"2180-2181","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neostigmine in Septic Shock\u2014A Story Too Good to Be True?"],"prefix":"10.1097","volume":"54","author":[{"given":"Alexandra Julia","family":"Lipa","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-1077","authenticated-orcid":false,"given":"Christian","family":"Schoergenhofer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"R1-20260806","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/CCM.0000000000007051","article-title":"Effect of neostigmine on attenuation of proinflammatory cytokines when given as an adjuvant therapy in septic shock: A randomized control trial.","volume":"54","author":"Bashni","year":"2026","journal-title":"Crit Care Med"},{"key":"R2-20260806","doi-asserted-by":"crossref","first-page":"855764","DOI":"10.3389\/fphar.2022.855764","article-title":"Efficacy and safety of neostigmine adjunctive therapy in patients with sepsis or septic shock: A randomized controlled trial.","volume":"13","author":"El-Tamalawy","year":"2022","journal-title":"Front Pharmacol"},{"key":"R3-20260806","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1473-3099(01)00093-7","article-title":"Immunotherapy of sepsis.","volume":"1","author":"van der Poll","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"R4-20260806","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14740\/jocmr2251w","article-title":"Procalcitonin kinetics in the first 72 hours predicts 30-day mortality in severely ill septic patients admitted to an intermediate care unit.","volume":"7","author":"Pieralli","year":"2015","journal-title":"J Clin Med Res"},{"key":"R5-20260806","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock.","volume":"370","author":"Yealy","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:45Z","timestamp":1786048725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007169","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}